Pinjaroen, N.; Chailapakul, P.; Sriphoosanaphan, S.; Chuaypen, N.; Tangkijvanich, P.
Predictive Role of Pretreatment Circulating miR-221 in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. Diagnostics 2023, 13, 2794.
https://doi.org/10.3390/diagnostics13172794
AMA Style
Pinjaroen N, Chailapakul P, Sriphoosanaphan S, Chuaypen N, Tangkijvanich P.
Predictive Role of Pretreatment Circulating miR-221 in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. Diagnostics. 2023; 13(17):2794.
https://doi.org/10.3390/diagnostics13172794
Chicago/Turabian Style
Pinjaroen, Nutcha, Piyawan Chailapakul, Supachaya Sriphoosanaphan, Natthaya Chuaypen, and Pisit Tangkijvanich.
2023. "Predictive Role of Pretreatment Circulating miR-221 in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization" Diagnostics 13, no. 17: 2794.
https://doi.org/10.3390/diagnostics13172794
APA Style
Pinjaroen, N., Chailapakul, P., Sriphoosanaphan, S., Chuaypen, N., & Tangkijvanich, P.
(2023). Predictive Role of Pretreatment Circulating miR-221 in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. Diagnostics, 13(17), 2794.
https://doi.org/10.3390/diagnostics13172794